TF VENTURE CAPITAL MANAGEMENT CO., LTD.
TF VENTURE CAPITAL MANAGEMENT CO., LTD. is a Seed, Series A, Series B, Series C+ and early-stage fund in the US and China investing in life-sciences, biotechnology, therapeutics, drug-delivery and medical-devices.
- Stages
- Seed, Series A, Series B, Series C+, early-stage
- Sectors
- life-sciences, biotechnology, therapeutics, drug-delivery, medical-devices
- Invests in
- US-wide, China
- Actively investing
- Yes
- Founded
- 2014
- Assets under management
- $1B+
- Website
- tfcapital.net
Check size not disclosed
Thesis
TF Venture Capital Management Co., Ltd., also known as TF Capital, is a venture capital firm established in 2014 and based in Shanghai, China. The firm concentrates its investments in the life sciences and biotechnology sectors, specifically targeting early-stage and growth-stage companies. Their investment thesis revolves around backing biotech firms involved in therapeutics, drug delivery, medical devices, and related services, providing support from early development through to commercialization. TF Capital aims to leverage U.S. innovation alongside China's cost advantages to create value. They seek out high-barrier, biologically differentiated assets and scalable technology platforms, as well as investing in China's leading biotech companies to capitalize on globalization opportunities. Their geographic focus includes China and U.S. innovation, with stage preferences ranging from seed to growth stages.
Common questions
Does TF VENTURE CAPITAL MANAGEMENT CO., LTD. invest at the Seed stage?
Yes. TF VENTURE CAPITAL MANAGEMENT CO., LTD. lists Seed, Series A, Series B, Series C+ and early-stage among the stages it invests in.
Where does TF VENTURE CAPITAL MANAGEMENT CO., LTD. invest?
TF VENTURE CAPITAL MANAGEMENT CO., LTD. invests in the US and China.